A practical reference on HGF/c-Met: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-31. Anything still debated is marked as such rather than presented as settled.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
The proposed mechanism of dihexa involves activation of hepatocyte growth factor and its receptor, c-Met. In cell models, this signaling pathway is associated with dendritic spine formation and synaptic reorganization. Dihexa is described as a stabilized analog of angiotensin IV, which also interacts with related systems. However, the precise binding profile and downstream effects remain incompletely characterized. Most mechanistic evidence comes from in vitro assays and rodent studies rather than human trials.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine | Marketed for research use in some regions. |
| Human clinical data | Limited or absent | Most evidence is from cell and animal studies. |
| Primary proposed pathway | HGF/c-Met signaling | Angiotensin IV-related activity also reported. |
| Common study models | Rodent neurons and behavioral tasks | Results may not translate directly to humans. |
| Key uncertainty | Bioavailability and brain exposure | Questions remain about absorption and target engagement. |
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
Exercise intolerance, Abnormal muscle fatigue (premature fatigue and/or inability to get into second wind), muscle pain (myalgia), cramping or muscle stiffness during and/or after exercise, Shortness of breath (dyspnea), or rapid breathing (tachypnea), or heavy breathing (hyperpnea), or both (exercise hyperventilation) Inappropriate rapid heart rate in response to exercise (tachycardia), Exaggerated cardiorespiratory (breath and heart rate combined) response to exercise (dyspnea/tachypnea/hyperpnea and tachycardia), Exercise-induced myogenic hyperuricemia (exercise-induced accelerated breakdown of purine nucleotides in muscle via adenylate kinase reaction and purine nucleotide cycle), Transient muscle contracture or pseudomyotonia (like a really bad cramp that can last for hours, which is myogenic and EMG silent), May have progressive muscle weakness, May have a pseudoathletic appearance (hypertrophy or pseudohypertrophy) especially of the calves, Reddish-brown urine (myoglobinuria) and considerable breakdown of muscle tissue (rhabdomyolysis). The degree of symptoms varies greatly from person to person and is dependent on the severity of enzymatic or transport protein defect. In extreme cases it can lead to rhabdomyolysis. The symptoms experienced also depend on which metabolic pathway is impaired, as different metabolic pathways produce ATP at different time periods during activity and rest, as well as the type of activity (anaerobic or aerobic) and its intensity (level of ATP consumption).
Sport in modern India is a nexus of little-known indigenous traditions and commercial sporting events with worldwide reach. Traditional sports such as kabaddi and kho-kho have experienced a resurgence, attracting large television audiences; on the other hand, kushti wrestling in rural akharas—often regarded by its practitioners as not so much a sport as a physical and moral regimen—has continued to survive away from the exposure of broadcasting. Cricket is India's most watched sport and a multi-billion dollar industry. The widespread popularity of chess among youth in southern India culminated in 18-year-old Gukesh Dommaraju of Chennai winning the undisputed World Chess Champion title in 2024. British intervention reshaped India's athletic landscape. It introduced cricket, football and field hockey and institutionalised polo—a sport whose history is a case of reverse migration from India to the West. Today, at the rural grassroots level, government initiatives like "Khelo India" have democratised athletics for traditionally overlooked youth. Rural soccer programs have employed teamwork to break down old caste barriers. State initiatives such as the Target Olympic Podium Scheme have expanded resources for female athletes; meanwhile, the prominent international victories of figures like boxer Mary Kom and badminton player P. V. Sindhu have challenged traditional gender stereotypes in sports. India has won eight men's cricket ICC tournament titles: two Cricket World Cups, three T20 World Cups, and three Champions Trophy titles.
Money serves three purposes: a store of value, a medium of exchange, and a unit of account. According to The Economist in 2014, bitcoin functions best as a medium of exchange. In 2015, The Economist noted that bitcoins had three qualities useful in a currency: they are "hard to earn, limited in supply and easy to verify". However, a 2018 assessment by The Economist stated that cryptocurrencies met none of these three criteria. Per some researchers, as of 2015, bitcoin functions more as a payment system than as a currency. In 2014, economist Robert J. Shiller wrote that bitcoin has potential as a unit of account for measuring the relative value of goods, as with Chile's Unidad de Fomento, but that "Bitcoin in its present form... doesn't really solve any sensible economic problem". In 2017, François Velde, senior economist at the Chicago Fed, described bitcoin as "unlikely by itself to replace monies in well-functioning monetary systems." The legal status of bitcoin varies substantially from one jurisdiction to another. Because of its decentralized nature and its global presence, regulating bitcoin is difficult. However, the use of bitcoin can be criminalized, and shutting down exchanges and the peer-to-peer economy in a given country would constitute a de facto ban. The use of bitcoin by criminals has attracted the attention of financial regulators, legislative bodies, and law enforcement. Nobel-prize winning economist Joseph Stiglitz says that bitcoin's anonymity encourages money laundering and other crimes. This is the main justification behind bitcoin bans.
Professor John Joseph Murray, Professor of Child Dental Health, University of Newcastle. For services to Dental Health. Raymond Godfrey Owen, . For public service in Wales, especially to the Police. George Hubbard Makgill, The Viscount of Oxfuird, For political service. David John Parker, Consultant Cardiac Surgeon, St George's Hospital, London. For services to Medicine. Roderick Sayers Paul, lately Chairman, British Water. For services to the Water Industry and to Export. Professor John Pitkeathly Ian Percy, Chairman, Accounts Commission for Scotland. For services to Accounting and to Local Authorities. Rupert Perry, President and Chief Executive Officer, EMI Europe. For services to the Recording Industry. Anna Bridget Plowden. For conservation services to Museums. Christopher Bernard Poole. For political service. Andrew Popat. For political service. David Edwin Potter, Chairman and Chief Executive, Psion plc. For services to the Manufacturing Industry. Bernard Albert Price, County Clerk and Chief Executive, Staffordshire County Council. For services to Local Government. Colonel John Richard George Putnam, . For services to the Territorial Auxiliary and Volunteer Reserve Association in South East England. John Anthony Ransford, lately Honorary Secretary, Association of Directors of Social Services. For services to Social Work. Steven Geoffrey Redgrave, . For services to Rowing. Timothy John Rix. For services to Publishing. Dermot James Roaf. For political and public service. James Donald Robson, , Leader, Durham County Council. For services to Local Government.
Sources: en.wikipedia.org
=== Symbolism === The fleur-de-lis, commonly with a five-point star in each of outer lobe, is a more widely used symbol of the Scout Movement. The fleur-de-lis represents the north point on a map or compass and is intended to point Scouts on the path to service. The three lobes on the fleur-de-lis represent the three parts of the Scout Promise: duty to God, service to others and obedience to the Scout Law. A "bond", tying the three lobes of the fleur-de-lis together, symbolizes the family of Scouts. The two five-point stars stand for truth and knowledge, with the ten points representing the ten points of the Scout Law. The WOSM emblem adds an encircling rope, tied with a knot at the base, which symbolises the unity and bond of the Scout Movement and uses purple and white colours. In heraldry, the white of the fleur-de-lis and rope denotes purity and the royal purple denotes leadership and service.
== Interactions == There are several notable drug interactions with progesterone. Certain selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, paroxetine, and sertraline may increase the GABAA receptor-related central depressant effects of progesterone by enhancing its conversion into 5α-dihydroprogesterone and allopregnanolone via activation of 3α-HSD. Progesterone potentiates the sedative effects of benzodiazepines and alcohol. Notably, there is a case report of progesterone abuse alone with very high doses. 5α-Reductase inhibitors such as finasteride and dutasteride inhibit the conversion of progesterone into the inhibitory neurosteroid allopregnanolone, and for this reason, may have the potential to reduce the sedative and related effects of progesterone. Progesterone is a weak but significant agonist of the pregnane X receptor (PXR), and has been found to induce several hepatic cytochrome P450 enzymes, such as CYP3A4, especially when concentrations are high, such as with pregnancy range levels. As such, progesterone may have the potential to accelerate the metabolism of various medications.
Abortive initiation, the unproductive cycling of RNA polymerase before the promoter escape transition, results in short RNA fragments of around 9 bp in a process known as abortive transcription. The extent of abortive initiation depends on the presence of transcription factors and the strength of the promoter contacts.
== Mechanism == Three main changes are seen in the mechanism of Raynaud's phenomenon: reduced blood flow, blood vessel constriction, and neurogenic, inflammatory, and immune responses. It is induced by emotional stress and coldness. In all cases, the primary cause is an underlying hyperactivation of the sympathetic nervous system, although the exact pathophysiology differs depending on the type. In the primary type, there is an increase in sensitivity due to the issues mentioned above, resulting in vasoconstriction. In the secondary type, normal activity of blood vessels is disrupted due to the same issues, causing vasoconstriction which leads to ischemia and tissue death.
== Drug combination == Some ingredients such as caffeine, creatine and β-alanine are found in nearly all pre-workout blends, but each branded product is a "proprietary blend" with an average of 18 different ingredients, the exact composition and proportions of which can vary widely between different products. Additionally legal psychoactive substances occasionally used in these proprietary blends that are typically legal include 5-HTP, tyrosine, and yohimbine. Although these products are not banned, the Food and Drug Administration warns consumers to be cautious when consuming pre-workout. Benzodiazepines can cause death when mixed with other CNS depressants such as opioids, alcohol, or barbiturates. Alcohol and cocaine (for example coca wine) increase cardiovascular toxicity. Opioids or cocaine taken with ecstasy or amphetamines also result in additional acute toxicity.
Sources: en.wikipedia.org
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.
Preclinical research has focused on synaptic growth, cognitive performance in animals, and HGF/c-Met signaling. These are experimental findings, not established treatments.
Legality varies by country and intended use. It is commonly sold as a research chemical, and sales for human consumption may be restricted. Local regulations should be checked.
Dihexa has been reported to activate hepatocyte growth factor/c-Met signaling in cell studies. This pathway is linked to synapse formation and neuronal remodeling. The exact molecular interactions are not fully understood.